Endoscopy 2022; 54(S 01): S93-S94
DOI: 10.1055/s-0042-1744784
Abstracts | ESGE Days 2022
ESGE Days 2022 Oral presentations
10:00–11:00 Saturday, 30 April 2022 Club A. Barrett's Related neoplasia: is endoscopythe cure?

FOCAL CRYOBALLOON ABLATION WITH 8SEC DOSE HAS SIMILAR EFFICACY AS 10SEC FOR TREATMENT OF BARRETT’S ESOPHAGUS RELATED NEOPLASIA

C.N. Frederiks
1   St. Antonius Hospital, Gastroenterology and Hepatology, Nieuwegein, Netherlands
2   University Medical Center Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands
,
A. Overwater
1   St. Antonius Hospital, Gastroenterology and Hepatology, Nieuwegein, Netherlands
2   University Medical Center Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands
,
L. Alvarez Herrero
1   St. Antonius Hospital, Gastroenterology and Hepatology, Nieuwegein, Netherlands
,
A. Alkhalaf
3   Isala Hospital, Gastroenterology and Hepatology, Zwolle, Netherlands
,
B.E. Schenk
3   Isala Hospital, Gastroenterology and Hepatology, Zwolle, Netherlands
,
A. Repici
4   Humanitas Research Hospital, Gastroenterology and Hepatology, Milan, Italy
,
J.J. Bergman
5   Amsterdam University Medical Center, Gastroenterology and Hepatology, Amsterdam, Netherlands
,
R.E. Pouw
5   Amsterdam University Medical Center, Gastroenterology and Hepatology, Amsterdam, Netherlands
,
R. Bisschops
6   University Hospital Leuven, Gastroenterology and Hepatology, Leuven, Belgium
,
R.J. Haidry
7   University College London Hospitals, Gastroenterology and Hepatology, Londen, United Kingdom
,
T. Beyna
8   Evangelical Hospital Dusseldorf, Gastroenterology and Hepatology, Dusseldorf, Germany
,
H. Neuhaus
8   Evangelical Hospital Dusseldorf, Gastroenterology and Hepatology, Dusseldorf, Germany
,
B.L.A.M. Weusten
1   St. Antonius Hospital, Gastroenterology and Hepatology, Nieuwegein, Netherlands
2   University Medical Center Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands
› Author Affiliations
 

Aims Focal cryoballoon ablation (FCBA) is currently investigated for treatment of Barrett’s esophagus (BE) related neoplasia in a European multicenter study (Euro-Coldplay; NTR NL7253). After inclusion of 28/107 patients, the initial dose of 10sec was lowered to 8sec. In this current study, we compared the efficacy and safety of single FCBA treatment with 10sec versus 8sec in patients with limited BE (C≤2/M≤5).

Methods All 28 patients treated with 10sec were compared with the first 28 patients treated with 8sec. Treatments were performed by trained endoscopists in 7 Barrett referral centers. The gastroesophageal junction was ablated circumferentially followed by all visible BE. To assess efficacy after a single FCBA, three expert adjudicators, blinded for treating physician and dosages, compared pre- and post-treatment images. Outcomes included median BE surface regression and stricture rate.

Results We included 56 patients (10sec n=28, 8sec n=28) with a median BE of C0M2 and comparable baseline characteristics. FCBA was technically successful in 27/28 (96%) patients for both cohorts. The median BE surface regression was comparable for 10sec and 8sec (80% [95%CI 75-90] and 80% [95%CI 66-90], respectively; p=0.65). Strictures requiring dilation were seen in 19% [95%CI 4-33] and 15% [95%CI 4-30] of the 10sec and 8sec group respectively (p=1.00). Two patients among the 10sec group developed a severe stricture requiring>3 dilations.

Table 1 Per-protocol analysis of primary outcomes after single FCBA treatment.

10sec (n=27)

8sec (n=27)

P-value [1]

Median BE surface regression [2],% (p25-p75)

80 (75-92)

80 (59–92)

0.65

Stricture requiring dilation, n (%)

5 (19)

4 (15)

1.00

Severe stricture requiring>3 dilations, n (%)

2 (7)

0 (0)

0.44

Number of dilations, median (range)

1 (1-8)

2 (1-3)

0.78

1For Mann-Whitney U test, Chi-squared test or Fisher’s exact test.


2Not assessable in one patient (8sec) due to missing pre-treatment images.


Conclusions In limited BE, single-session FCBA with 8sec has shown similar efficacy as compared to 10sec, and may theoretically result in less and less severe strictures. Therefore, further study into using 8sec dosing is recommended.



Publication History

Article published online:
14 April 2022

© 2022. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany